Fertility preservation after chemotherapy for Hodgkin lymphoma (Q37709972)

22 August 2017

1 reference

title

Fertility preservation after chemotherapy for Hodgkin lymphoma. (English)

1 reference

22 August 2017

1 reference

Marleen A E van der Kaaij

1

1 reference

22 August 2017

Jannie van Echten-Arends

2

1 reference

22 August 2017

Arnold H M Simons

3

1 reference

22 August 2017

Hanneke C Kluin-Nelemans

4

1 reference

22 August 2017

publication date

1 December 2010

1 reference

22 August 2017

published in

Hematological Oncology

1 reference

22 August 2017

volume

28

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

168-179

1 reference

Gonadal dysfunction in patients receiving chemotherapy for cancer

22 August 2017

cites work

1 reference

Use of testosterone to prevent cyclophosphamide-induced azoospermia.

21 January 2018

1 reference

Effect of drug treatment for lymphoma on male reproductive capacity. Studies of men in remission after therapy.

21 January 2018

1 reference

Male fertility after VAPEC-B chemotherapy for Hodgkin's disease and non-Hodgkin's lymphoma

21 January 2018

1 reference

Spermatogenesis after cancer treatment: damage and recovery

21 January 2018

1 reference

7 January 2021

The influence of radiation on fertility in man.

1 reference

7 January 2021

Rapid recovery of spermatogenesis after mitoxantrone, vincristine, vinblastine, and prednisone chemotherapy for Hodgkin's disease

1 reference

7 January 2021

Semen quality in men with malignant diseases before and after therapy and the role of cryopreservation

1 reference

7 January 2021

The impact of chemotherapy on male fertility: a survey of the biologic basis and clinical aspects

1 reference

7 January 2021

Hormonal approaches to preservation and restoration of male fertility after cancer treatment

1 reference

7 January 2021

Gonadal function in males after chemotherapy for early-stage Hodgkin's lymphoma treated in four subsequent trials by the European Organisation for Research and Treatment of Cancer: EORTC Lymphoma Group and the Groupe d'Etude des Lymphomes de l'Adult

1 reference

7 January 2021

Impact of cyclophosphamide on long-term reduction in sperm count in men treated with combination chemotherapy for Ewing and soft tissue sarcomas

1 reference

7 January 2021

Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy

1 reference

7 January 2021

Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer

1 reference

7 January 2021

Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease

1 reference

7 January 2021

Ovarian function preservation in the cancer patient

1 reference

7 January 2021

Sperm quality before treatment in patients with early stage Hodgkin's lymphoma enrolled in EORTC-GELA Lymphoma Group trials

1 reference

7 January 2021

Male gonadal dysfunction in patients with Hodgkin's disease prior to treatment

1 reference

7 January 2021

Testicular cancer and Hodgkin's disease: evaluation of semen quality

1 reference

7 January 2021

Recovery of impaired pretreatment spermatogenesis in testicular cancer

1 reference

7 January 2021

Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trials

1 reference

7 January 2021

Testicular dysfunction in Hodgkin's disease before and after treatment

1 reference

7 January 2021

Post-treatment parenthood in Hodgkin's lymphoma survivors

1 reference

7 January 2021

Pregnancy outcome in patients treated for Hodgkin's disease

1 reference

7 January 2021

1 reference

7 January 2021

1 reference

7 January 2021

Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group

1 reference

7 January 2021

Fertility among female hodgkin lymphoma survivors attempting pregnancy following ABVD chemotherapy.

1 reference

7 January 2021

Twenty years experience with semen cryopreservation in testicular cancer patients: who needs it?

1 reference

7 January 2021

Semen cryopreservation, utilisation and reproductive outcome in men treated for Hodgkin's disease

1 reference

7 January 2021

Use rate and assisted reproduction technologies outcome of cryopreserved semen from 629 cancer patients

1 reference

7 January 2021

Fertility after cancer: a prospective review of assisted reproductive outcome with banked semen specimens

1 reference

7 January 2021

Sperm cryopreservation for male patients with cancer: an epidemiological analysis at the University of Pennsylvania

1 reference

7 January 2021

Characterization of sperm chromatin quality in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy

1 reference

7 January 2021

Intracytoplasmic sperm injection (ICSI) using cryopreserved sperm from men with malignant neoplasm yields high pregnancy rates

1 reference

7 January 2021

Testicular sperm extraction and ICSI in patients with post-chemotherapy non-obstructive azoospermia.

1 reference

7 January 2021

Testicular sperm retrieval in the management of chemotherapy induced azoospermia

1 reference

7 January 2021

GnRH analog, leuprorelin acetate, promotes regeneration of rat spermatogenesis after severe chemical damage

1 reference

7 January 2021

Luteinizing hormone-releasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys

1 reference

7 January 2021

Attempted protection of spermatogenesis from irradiation in patients with seminoma by D-Tryptophan-6 luteinizing hormone releasing hormone

1 reference

7 January 2021

Reproductive Toxicity with and without LHRHAAdministration During Adjuvant Chemotherapy in Patients with Germ Cell Tumors

1 reference

7 January 2021

Lack of gonadal protection by medroxyprogesterone acetate-induced transient medical castration during chemotherapy for testicular cancer

1 reference

7 January 2021

Failure to preserve fertility in patients with Hodgkin's disease

1 reference

7 January 2021

How should the clinical efficiency of oocyte cryopreservation be measured?

1 reference

7 January 2021

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients

1 reference

7 January 2021

Pregnancy after human oocyte cryopreservation.

1 reference

7 January 2021

Highly efficient vitrification method for cryopreservation of human oocytes

1 reference

7 January 2021

Report of four donor-recipient oocyte cryopreservation cycles resulting in high pregnancy and implantation rates

1 reference

7 January 2021

Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies

1 reference

7 January 2021

Children born after cryopreservation of embryos or oocytes: a systematic review of outcome data

1 reference

7 January 2021

ASRM Practice Committee response to Rybak and Lieman: elective self-donation of oocytes

1 reference

7 January 2021

Livebirth after orthotopic transplantation of cryopreserved ovarian tissue

1 reference

7 January 2021

Pregnancy after Transplantation of Cryopreserved Ovarian Tissue in a Patient with Ovarian Failure after Chemotherapy

1 reference

7 January 2021

Fertility preservation: successful transplantation of cryopreserved ovarian tissue in a young patient previously treated for Hodgkin's disease.

1 reference

7 January 2021

Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue

1 reference

7 January 2021

Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients.

1 reference

7 January 2021

Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield

1 reference

7 January 2021

Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience

1 reference

7 January 2021

Cytotoxic-induced ovarian failure in women with Hodgkin's disease. I. Hormone function

1 reference

7 January 2021

The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease

1 reference

7 January 2021

Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury

1 reference

7 January 2021

GnRH agonist therapy as ovarian protectants in female patients undergoing chemotherapy: a review of the clinical data

1 reference

7 January 2021

Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis

1 reference

7 January 2021

Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: prospective randomized study

1 reference

7 January 2021

Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial

1 reference

7 January 2021

Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).

1 reference

7 January 2021

Cancer and male infertility

1 reference

7 January 2021

Male reproductive potential after MOPP therapy for Hodgkin's disease: a long-term survey

1 reference

7 January 2021

Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD

1 reference

7 January 2021

Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy

1 reference

7 January 2021

Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.

1 reference

7 January 2021

Testicular function in young men in long-term remission after treatment for the early stages of Hodgkin's disease

1 reference

7 January 2021

Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy

1 reference

7 January 2021

The consequences of the chemotherapy of Hodgkin's disease: The 10th David A. Karnofsky Memorial Lecture

1 reference

7 January 2021

The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male

1 reference

7 January 2021

Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy

1 reference

7 January 2021

Fertility in young men and women after treatment for lymphoma: a study of a population

1 reference

7 January 2021

Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen

1 reference

7 January 2021

Cyclical combination chemotherapy and gonadal function. Retrospective study in males

1 reference

7 January 2021

Follicle stimulating hormone levels as a predictor of recovery of spermatogenesis following cancer therapy

1 reference

7 January 2021

Testicular dysfunction after cyclophosphamide-vincristine-procarbazine-prednisolone chemotherapy for advanced Hodgkin's disease. A long-term follow-up study.

1 reference

7 January 2021

Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease

1 reference

7 January 2021

Follow-up of sperm concentration and motility in patients with lymphoma

1 reference

7 January 2021

Gonadal function following ABVD therapy for Hodgkin's disease

1 reference

7 January 2021

Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease

1 reference

7 January 2021

Fertility in male patients with advanced Hodgkin lymphoma treated with BEACOPP: a report of the German Hodgkin Study Group (GHSG).

1 reference

7 January 2021

Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report

1 reference

7 January 2021

ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results

1 reference

7 January 2021

Evaluation of the efficacy of the VEEP regimen in adult Hodgkin's disease with assessment of gonadal and cardiac toxicity

1 reference

7 January 2021

Female Reproductive Potential after Treatment for Hodgkin's Disease

1 reference

7 January 2021

Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease

1 reference

7 January 2021

Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease.

1 reference

7 January 2021

Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease

1 reference

7 January 2021

Pregnancies and menstrual function before and after combined radiation (RT) and chemotherapy (TVPP) for Hodgkin's disease

1 reference

7 January 2021

Assessment of ovarian reserve following ovarian tissue banking and/or GnRH-a co-treatment prior to chemotherapy in patients with Hodgkin's disease

1 reference

7 January 2021

Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients

1 reference

7 January 2021

Gonadotropin-releasing hormone agonist decreases chemotherapy-induced gonadotoxicity and premature ovarian failure in young female patients with Hodgkin lymphoma.

1 reference

7 January 2021

Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy

1 reference

7 January 2021

Preservation of fertility and ovarian function and minimization of chemotherapy-induced gonadotoxicity in young women by GnRH-a

1 reference

7 January 2021

Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma

1 reference

7 January 2021

Use of a gonadotropin-releasing hormone analog for protection against premature ovarian failure during cyclophosphamide therapy in women with severe lupus

1 reference

7 January 2021

Use of GnRH analogs for functional protection of the ovary and preservation of fertility during cancer treatment in adolescents: a preliminary report

1 reference

7 January 2021

Preservation of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemotherapy

1 reference

7 January 2021

Identifiers

DOI

10.1002/HON.939

1 reference

22 August 2017

1 reference